Your Article Summary
Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin (pramipexole) formulation for the treatment of Parkinson's disease
Boehringer Ingelheim, 06/29/09
AVI BioPharma, Inc. , a developer of RNA-based drugs, announced that immediately following the close of the U.S. markets it will join the broad-market Russell 3000 Index following Russell Investments' annual reconstitution of its comprehensive set of U.S. and global equity indexes.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
I-Flow Announces Availability of ON-Q SilverDressings
Wounds, 10/09/09
Medical Devices: How Do You Know They Are Safe
AMN Healthcare, 10/12/09
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Article Search
Sponsor


See Latest Articles


